PHK
HZNP

Point72 Hong Kong’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Point72 Hong Kong’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,297
Closed -$901K – 2589
2022
Q2 		$901K Sell
11,297
-10,206
-47% -$967K 0.03% 561
2022
Q1 		$2.26M Buy
21,503
+21,372
+16,315% +$2.08M 0.08% 293
2021
Q4 		$14K Buy
+131
New +$14.3K ﹤0.01% 1603
2021
Q3 		– Sell
-14,785
Closed -$1.38M – 2627
2021
Q2 		$1.38M Buy
+14,785
New +$1.36M 0.04% 581
2020
Q4 		– Sell
-19,888
Closed -$1.54M – 2184
2020
Q3 		$1.54M Buy
19,888
+19,758
+15,198% +$1.36M 0.16% 147
2020
Q2 		$7K Sell
130
-2,410
-95% -$103K ﹤0.01% 1020
2020
Q1 		$75K Buy
2,540
+1,527
+151% +$51.7K 0.03% 255
2019
Q4 		$37K Buy
+1,013
New +$31.1K 0.01% 757
2019
Q3 		– Sell
-7
Closed – – 1540
2019
Q2 		$0 Sell
7
-97
-93% -$2.46K ﹤0.01% 1564
2019
Q1 		$3K Buy
104
+89
+593% +$2.11K ﹤0.01% 876
2018
Q4 		$0 Buy
+15
New +$294 ﹤0.01% 1366
2018
Q2 		– Sell
-1,377
Closed -$20K – 1331
2018
Q1 		$20K Buy
+1,377
New +$20.3K 0.01% 621
2017
Q4 		– Sell
-652
Closed -$8K – 1228
2017
Q3 		$8K Sell
652
-389
-37% -$4.95K 0.01% 525
2017
Q2 		$12K Sell
1,041
-4,691
-82% -$58.4K 0.01% 454
2017
Q1 		$85K Buy
5,732
+5,710
+25,955% +$92.5K 0.11% 150
2016
Q4 		$0 Buy
+22
New +$399 ﹤0.01% 1115

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Point72 Hong Kong's HZNP Position: Q3 2022 in Review

Point72 Hong Kong sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 11,297 shares — an estimated $901K sold.

Point72 Hong Kong first reported a position in HZNP in Q4 2016 and held it in 16 quarters. The position peaked at $2.26M in Q1 2022. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Point72 Hong Kong reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 11,297 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $901K.
  • Point72 Hong Kong first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 16 quarters.
  • Point72 Hong Kong's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.26M in Q1 2022.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.